Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04728893
Title Efficacy and Safety of MK-1026 in Participants With Hematologic Malignancies (MK-1026-003)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.

nodal marginal zone lymphoma

Waldenstroem's macroglobulinemia

follicular lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

marginal zone B-cell lymphoma


ARQ 531

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN

No variant requirements are available.